Moneycontrol PRO

Sansaar

HomeNewsArch pharma

Arch Pharma

Jump to

CDR cell sees over 50% jump in loan recast requests in Q1

Around Rs 47,359 crore of loans were referred to the corporate debt restructuring (CDR) in just one month, which is over half of what was referred in the last year

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347